Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance (Q38950434)

7 September 2017

title

Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance (English)

1 reference

7 September 2017

1 reference

Shun-Fa Yang

1 reference

7 September 2017

Han-Lin Hsu

1 reference

7 September 2017

Tai-Kuang Chao

1 reference

7 September 2017

Chia-Jung Hsiao

1 reference

7 September 2017

Yung-Feng Lin

1 reference

7 September 2017

Chao-Wen Cheng

1 reference

7 September 2017

publication date

3 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

22.e11-22.e21

1 reference

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Nephronectin expression in nephrotoxic acute tubular necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin A2 heterotetramer: structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexins: linking Ca2+ signalling to membrane dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin II represents metastatic potential in clear-cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

The role of annexin A2 in tumorigenesis and cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Knockdown of annexin 2 decreases migration of human glioma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin A2 promotes glioma cell invasion and tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexins: from structure to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Cell migration: Rho GTPases lead the way

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.08.015

10.1016/J.UROLONC.2014.08.015

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference